Giripladib is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research. Reference standards of Giripladib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Giripladib [catalogue_number] => PA 07 67000 [category_ids] => ,78,70,82, [chemical_name] => [weight] => 745.25 [form] => C41H36ClF3N2O4S [cas] => 865200-20-0 [pslug] => 865200-20-0-giripladib-api-pa0767000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 07 67000
CAS :
Molecular Formula : C41H36ClF3N2O4S
Molecular Weight : 745.25
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....